Mirae Asset Global Investments’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,114
Closed -$816K 2655
2024
Q1
$816K Buy
21,114
+332
+2% +$5.27K ﹤0.01% 1647
2023
Q4
$255K Buy
20,782
+63
+0.3% +$591 ﹤0.01% 2263
2023
Q3
$311K Buy
20,719
+518
+3% +$10.8K ﹤0.01% 2110
2023
Q2
$656K Sell
20,201
-913
-4% -$33.3K ﹤0.01% 1822
2023
Q1
$826K Buy
21,114
+1,596
+8% +$78.1K ﹤0.01% 1639
2022
Q4
$1.03M Buy
19,518
+1,547
+9% +$75.3K ﹤0.01% 1476
2022
Q3
$809K Buy
17,971
+3,640
+25% +$157K ﹤0.01% 1603
2022
Q2
$522K Buy
+14,331
New +$521K ﹤0.01% 1728
2021
Q1
Sell
-3,282
Closed -$207K 1652
2020
Q4
$207K Buy
+3,282
New +$204K ﹤0.01% 1511

Other funds holding SILK

Mirae Asset Global Investments's SILK Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 21,114 shares — an estimated $816K sold.

Mirae Asset Global Investments first reported a position in SILK in Q4 2020 and held it in 9 quarters. The position peaked at $1.03M in Q4 2022. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 21,114 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $816K.
  • Mirae Asset Global Investments first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Mirae Asset Global Investments's Silk Road Medical, Inc. Common Stock position peaked at $1.03M in Q4 2022.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.